Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes this is a deadbeat company going nowhere fast. That's why it keeps going day by day at close to zero interest trading beer money. But hey the 6 or 8 pumptards here say to the moon Alice. Lmao
If, by "our insurance salesman," you mean me:
1. I'm not your ANYTHING. Be very clear about that.
2. I never sold insurance. I was in IT.
3. I'm making a lot of money in the market right now. I don't have any current buy orders for BIEL and I don't want to hold BIEL because BIEL sucks (see #5).
4. I'm not bored and I'm not frustrated. Quite the contrary.
5. The MM's are the only ones making money here. They buy low and sell high -- retailers like you can only buy at .0002 or higher -- you can't get any 1's -- and you can't sell above .0002. On the rare occasion the MM's might throw you some table scraps, but if that happens, volume is so low that it's peanuts anyway.
Sorry, BIEL is a dead stock without buyers. I feel empathy for the shareholders who believed your bullshit and the other pumpers' bullshit, because we've all believed a MB pumper once or twice and been burned, but that's OTC gambling.
BIEL
Our insurance salesman is bored and frustrated he couldn't Buy any 1s for another flip
Remember when Andy hid that FDA Rejection letter? He uploaded it to the website but didn't tell shareholders about it. Somebody found it by digging deep into the website. Ahhhh those Wacky Whelans.
'member? I 'member.
Today we have Kelly claiming that she wishes she could tell us all about the great deals she's signed, but she can't. Shareholders decided to pump that there are NDA's in effect, even though Kelly never said there was an actual NDA.
SO reminiscent of Synergy. 'member Synergy? I 'member.
BIEL
Good grief, if that's OBVIOUS, why did you say this as if it meant something?
Those "insiders" have been rolling over their loans rather than demanding repayment of their convertible loans.
Hey srin, Good Grief is spot on. Some just love to poke the tiger with the stick. Make waves they can't get over.
BUY $BIEL$
So far it's a LOW VOLUME day - BUT almost trades are BUYS - we are going in the correct direction & with a little NEWS ^^^^^^^^
More Art BS, I have never blocked anyone from viewing my posts, you most likely placed me on 'Ignore' if you can't view my posts
<<<< you block me from seeing it ----- and all your other posts >>>>
Add that to the list:
BIEL's Money Back Guarantee is a scam
Forgoing Interest does not mean giving up Interest
Phantom Limb Pain is not experienced as real pain by patients
Mundipharma never produced any sales for BIEL
>>>Those "insiders" have been rolling over their loans rather than demanding repayment of their convertible loans.<<<
I think the obvious reasons they have been rolling them over are NOT really a POSITIVE. Maybe not having the funds to pay them all off at maturity, might be a NEGATIVE reason to the stockholders--- ya think?
Good Grief, Obviously the Whelans and RS are not going to demand loan repayment
There are 3 non-family lenders, each of whom could trigger the need for BIEL to access many more shares, than the 295 million remaining in their AS, if they demanded conversion. IMO, they still see a path to success for BIEL.
Issue Date// Balance ///// Note Holder
3/31/2018 121,346 $ McLeod Holdings Kenneth McLeod
6/30/2020 120,307 $ McLeod Holdings Kenneth McLeod
5/1/2018 402,006 $ T. Kim Nigel Timothy
12/20/2019 176,426 $ T. Kim Nigel Timothy
3/5/2020 86,458 $ T. Kim Nigel Timothy
11/19/2020 285,171 $ T. Kim Nigel Timothy
10/27/2022 25,623 $ T. Kim Nigel Timothy
5/8/2018 265,417 $ A. Humar Abhinav Humar
https://www.otcmarkets.com/file/company/financial-report/461038/content
So what's the big deal! All those clearances are what longtime investors already know about. Impressive, isn't it? Where are the SALES? Surely not enough to benefit the stockholders with a stock price of LOW TRIPLE ZEROS.
PS. You respond to my post but you block me from seeing it ----- and all your other posts? LOL, WOW!
They started selling a 720 version in Europe last year.
Now, apparently, they are shipping that 720-hour European version to the USA when you order the 250-hour version. It's a fire sale right now: $9.99 per device plus shipping, free shipping if you order $50 worth of KT Tape merch.
BIEL
RE: June19 post #341522 by bobby1151 Order info to buy the NEW Back Wrap with Velcro Holders for your Actipatch - Call 866-757-2284 & the SKU:BCK-WRPWTH-VLC Price $9.99 & ships FREE. - This back wrap is the easiest light weight unit to allow easy placement over your pain area!!!
So KT sells a 720 hour patch now ..?!
Kelly and Lauren are "friendly?"
Ask TripTrey how friendly they were to him on the BIEL Shareholder Group page.
Right, Tripsy?
BIEL
The biotech highway is strewn with the corpses of companies that finally got FDA clearance/approval and then couldn't sell their product.
BIEL is staggering down that highway. BIEL is still a zombie and not yet a corpse.
Corpses. We've all gambled on a few. It's like throwing money into a pyramid scheme -- you can sometimes profit if you get out before the pyramid collapses. (Remember Dendreon?)
BTW the most recent FDA clearance for ActiPatch makes the previous FDA clearances for ActiPatch rather pointless, wouldn't you agree?
BIEL
Those "insiders" are the Whelan sisters. St. John's is Lauren and IBEX is Kelly. From WHOM would they "demand repayment?" From Rick Staelin?
"Zero dilution" doesn't mean anything other than the O/S has expanded to reach the A/S so they can't dilute until they do a reverse split or increase the A/S from 25 billion.
Yes, it's a positive thing that the Whelans forewent loan interest. You need to stop there though. The absence of dilution and the absence of a demand for repayment by St. John's and IBEX are topics you really want to leave alone.
BIEL
For those, who, deliberately, "INFECTED" themselves with comprehension/thinking disability virus, a repeat post!!!!!
DR. OZ on Actipatch ( 10 years ago, go to 6:25 mark ), listen and weep!!!!!!!!
https://www.youtube.com/watch?v=qVvS2dC2-1s
Now, that Dr. Oz is Tsar.......BIEL...$$$$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!
----------------------------------------------------------------------
DonJoy Store
EME Replacement Device ( FSA / HSA APPROVED!!!!!!$$$$$$$ )
https://www.donjoystore.com/donjoyr-advantage-eme-replacement-device?srsltid=AfmBOoqJL5fv-Tkyjz7NmuwFnDcBi2nm4lqHTYznN6zlx5vaKarK8IsL
------------------------------------------------------------------------
A new over-the-counter treatment for heel pain caused by plantar fasciitis has received clearance from the United States FDA.
https://www.footandankleps.com/blog/new-wearable-therapy-provides-heel-pain-treatment
---------------------------------------------------------------------------
Actipatch Smart Insole -- NEW & IMPROVED!!!
https://unovita.com/products/smart-insoletm-heel-pain-relief?variant=47506240471349
https://shop.renovabiomed.it/it/prodotti/3402-soletta-e-fascia-smart-insole.html?sfnsn=wa
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-----------------------------------------------------------------------------------
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point of pain that changes how cells communicate pain. Research, technical information and studies available at www.RecoveryRx.co. It is an amazing device, unlike TENS units, RecoveryRx reduces pain without any kind of electrical stimulation feeling for the veteran. The antenna lasts 30 days, all Ortho, pain management, and PT providers can work through prosthetics (RecoveryRx is on the FSS) to get these on their patients for feedback and widespread use at the VA.
https://www.reddit.com/r/VeteransAffairs/comments/1gxclby/recoveryrx_now_available_through_prosthetics_for/?utm_source=share&utm_medium=mweb3x&utm_name=mweb3xcss&utm_term=1&utm_content=share_button
_________________________________________________
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!
-------------------------------------------------------------------------------------------------
Territory///Distributor////Products Distributed/// Website
Australia LMT ActiPatch RecoveryRx www.actipatch.com.au
Bangladesh Multiple Health Pharma ActiPatch
Bahrain STADA ActiPatch www.stada.com
Botswana Adcock Ingram ActiPatch www.actipatch.co.za
China CICD ActiPatch
Finland Kir Fix Oy ActiPatch www.kir-fix.fi
Iran Al Mutawafiqua Modern Drug ActiPatch
Ireland Inish Pharmacy ActiPatch www.inishpharmacy.com
Italy OneGlobe Bio ActiPatch/RecoveryRx www.oneglobebio.com
Jordan Al Mutawafiqua Modern Drug ActiPatch
Kuwait Modern Development ActiPatch/RRx www.mdmedical.co
Lebanon Al Mutawafiqua Modern Drug ActiPatch
Mexico Novro Med S.A. de C.V. RecoveryRx https://globaltech.com.mx/
Oman Modern Development ActiPatch/RRx www.mdmedical.co
Qatar Modern Development ActiPatch/RRx www.mdmedical.co
Saudi Arabia STADA ActiPatch www.stada.com
Spain Acuna Fombona ActiPatch www.acuna-fombona.com
Spain PRIM Group RecoveryRx www.prim.es
South Africa Adcock Ingram ActiPatch www.actipatch.co.za
Sweden Swedish Healthcare Academy ActiPatch www.actipatch.se
Taiwan Aphrodite Bio-Medical Technology ActiPatch www.abmt.com.tw
UAE Modern Development RecoveryRx www.mdmedical.co
United Kingdom Chemist4u ActiPatch www.chemist-4-u.com/
United States BioElectronics Corp RecoveryRx www.recoveryrx.co/
United States DonJoy DonJoy Advantage www.donjoyperformance.com
Yemen Al Mutawafiqua Modern Drug ActiPatch
https://www.bielcorp.com/distributors/
-----------------------------------------------------------------------------------------------------
From 3331:
BIEL 2025 - GONNA RUN!
pps > .001 after management drops some positive hint(s) - Golden Cross (already achieved) and Blue Sky Breakout gets technicians/chartists attention and pps out of the trips;
pps > .01 after management drops positive hint(s) convincing investors that break even cash flow positive (annual rev = $1.5 mil) will be achieved, along with the momentum from a 2021 like OTC run (Reddit crowd takes notice);
pps > .04 after pr indicates annual revs from Taiwan (in progress) can be valued at $10 mil;
pps > .08 after pr indicates annual revs from VA (in progress) can be valued at $10 mil;
pps > .12 after pr indicates annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil;
pps > .16 after pr indicates annual revs from new contracts (distributors, partners, etc.) can be valued at $10 mil;
pps > $1 (2026 - 2027)after loans are paid off and a stock buyback program is initiated.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652979
--------------------------------------------------------------------------------------------------------------
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!
ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE FROM KNOWN PAID BASHERS / PUMPERS / LIARS / MANIPULAYTORS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :
#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!
#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but a MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!
#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing
to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!
Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Here are the HARD FACTS about Bioelectronics corp ( BIEL ). below , backed by LINKS, NOT some made up LIES, BS WORD SALADS, SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS to DAMAGE one's IMAGE, to INFLUENCE POTENTIAL Investors to think negative about the Company's ( BIEL ) Future, to FALL for WORD SALADS of SCARE TACTICS, with an AGENDA !!!!!!!!!!!
BIEL$$$
-------------------------------------------------------------------------------------------------------------------------------------------
"If you’re looking for a powerful way to enhance your vitality, recover faster, and optimize your overall well-being, I highly recommend exploring PEMF therapy. It’s an investment in your health and a key component of my own personal journey towards peak performance.”
– Tony Robbins
Tony uses a high powered $25,000 PEMF machine but anyone can sample some of PEMF's capabilities with a $30 ActiPatch.
http://54.219.205.59/2023/07/17/the-energy-machine-that-powers-tony-robbins-exploring-the-transformative-power-of-pemf-therapy/
-------------------------------------------------------------------------------------------------------------------------------------------
Note, while NOPAIN ACT is a PREDICTION, YET, it is still a HARD FACT and VERY DOABLE!!!!!!!!
NOPAIN Act
Jan. 1, 2025
https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D
Just to highlight a few points::
(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—
Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).
“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—
“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or
II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.
“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—
“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or
“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;
that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>
Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—
(1) by aligning the margins of clause (v) with the margins of clause (iv);
(2) by redesignating clause (vi) as clause (vii); and
(3) by inserting after clause (v) the following new clause:
“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.
(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—
Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—
(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and
(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>
(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.
(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
___________________________________________________________________
The Pain Relief Therapy Market is characterized by a diverse competitive landscape, with several leading companies influencing market trends and driving innovation. Notable players include:
Stimwave: Specializes in innovative neuromodulation devices designed for chronic pain management, focusing on minimally invasive procedures to enhance patient outcomes.
Merk & co: A global leader in pharmaceutical products, Merck is actively involved in developing new analgesics and expanding its portfolio to address unmet medical needs in pain management.
Sanofi: Known for its wide range of pharmaceutical products, Sanofi is committed to advancing pain relief therapies through research and strategic partnerships.
Endo Pharmaceuticals.: Focused on pain management solutions, Endo is leveraging its expertise to develop unique formulations that cater to varying patient needs.
Calmare Therapeutics: Recognized for its innovative non-invasive pain relief technology, Calmare Therapeutics is pioneering new approaches to chronic pain treatment.
Johnson & Johnson: A key player in the healthcare sector, Johnson & Johnson is expanding its pain relief offerings through a combination of product innovation and strategic acquisitions.
Abbott: Engaged in developing advanced pain relief systems, Abbott is at the forefront of creating integrated solutions that combine medical devices and pharmaceuticals.
Allergan: Known for its aesthetic and therapeutic products, Allergan is also exploring pain relief therapies, particularly in the realm of nerve block techniques.
Beiersdorf: While primarily recognized for its skincare products, Beiersdorf is venturing into the pain relief market with topical analgesics and other innovative solutions.
Hisamitsu.: A leader in transdermal drug delivery systems, Hisamitsu is focused on developing patch-based pain relief solutions.
UltraCare Pro: Specializes in therapeutic modalities that enhance pain management through non-invasive techniques.
Iskra Medical.: Develops medical devices that facilitate pain relief, particularly in physiotherapy and rehabilitation settings.
Bioelectronics Corp: Innovates in the field of electroceuticals, offering non-drug solutions for pain management .
Medline : A major player in the healthcare supply chain, Medline is expanding its product offerings to include pain management solutions.
Pfizer: Actively involved in researching and developing new pain relief medications to address chronic pain issues.
Each of these companies plays a vital role in shaping the Pain Relief Therapy Market through product innovations, market expansions, and strategic partnerships, contributing to the overall growth and development of the sector.
Moreover, consumer awareness regarding pain management options is on the rise. Patients are becoming more informed about their choices, leading to increased demand for customized solutions that cater to individual needs. This trend is prompting companies to focus on product customization and the development of tailored therapies.
Emerging technologies, such as wearable devices and Internet of Things (IoT) solutions, are also shaping the future of the Pain Relief Therapy Market. These innovations allow for continuous monitoring of patients' conditions, enabling timely interventions and adjustments to treatment plans based on real-time data.
https://www.openpr.com/news/3785778/pain-relief-therapy-market-industry-dynamics-and-contributions
__________________________________________________________________
CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1809-P)
“Access to Non-Opioid Treatments for Pain Relief
…We are proposing that seven drugs and one device qualify as non-opioid treatments for pain relief, and we propose these products be paid separately in both the HOPD and ASC settings starting in CY 2025…”
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center
CONCLUSION
"The medical device market is poised for significant growth across all major regions, driven by technological advancements, increasing healthcare spending, and a global focus on improving healthcare outcomes. London and the UK continue to position themselves as leaders in medical device innovation, while Europe remains a regulatory-driven but stable market. Asia offers the most dynamic growth opportunities, with countries like China and India playing pivotal roles. Meanwhile, the USA maintains its dominance as the largest medical device market, supported by advanced R&D and regulatory frameworks. Investors looking to capitalize on these trends should consider region-specific opportunities, keeping an eye on the evolving regulatory landscapes and technological innovations shaping the industry."
https://iotworldmagazine.com/2024/09/05/2420/a-review-of-medical-device-market-size-reports-2024-2025-in-london-u-europe-asia-and-usa-focused-on-growth-forecast-and-segments
REFERENCES
Fortune Business Insights: https://www.fortunebusinessinsights.com/
MarketsandMarkets: https://www.marketsandmarkets.com/
Mordor Intelligence: https://www.mordorintelligence.com/
Gov.UK: https://www.gov.uk/
GlobalData: https://www.globaldata.com/
TechNavio: https://www.technavio.com/
Statista: https://www.statista.com/
Emergo: https://www.emergobyul.com/
Frost & Sullivan: https://www.frost.com/
Allied Market Research: https://www.alliedmarketresearch.com/
BMI Research: https://www.bmiresearch.com/
IBISWorld: https://www.ibisworld.com/
McKinsey: https://www.mckinsey.com/
Grand View Research: https://www.grandviewresearch.com/
----------------------------------
Globe Newswire via NewsMeiaWire
Sree Koneru, PhD Joins the Board of BioElectronics Corporation
FREDERICK, MD December 3, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC:
BIEL a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD.
https://www.facebook.com/story.php?story_fbid=1120914580039912&id=100063641406505
___________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing
PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.
https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/
MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
___________________________________________________________
News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
Ortho Alliance, 11 Orthopedic Surgery Centers, 'Optimal Recovery' with Pre/Post-Op RecoveryRx
https://orthoalliance.com/optimal-recovery/
Smart Approach Recovery
https://recoveryrx.carrd.co/
Kelly Cove Mobility
https://youtu.be/jljs7QPX7KE
RecoveryRx Veterinary
https://rrxvet.carrd.co/
TES Veterinary Physiotherapist
https://vetphysiodevon.com/vet-recovery-rx
Actipatch Taiwan
https://www.actipatchtw.com/general-1
Actipatch Sweden
https://rehabat.se/products/actipatch-mot-muskel-och-ledsmarta-och-kna-och-ryggsmarta
Actipatch Italy
https://alaction.it/
Actipatch Bulgaria
https://actipatch.bg/
Actipatch Finland
https://www.facebook.com/watch/?mibextid=SphRi8&v=1026096241843857&rdid=0EAph2C6CZ4xryHY
ActiPatch STADA
https://www.linkedin.com/posts/kelly-whelan-5ba88115_distribution-painrelief-stada-ugcPost-7274483449602748417-__ZB/
BIEL announces publication of Canine OA Study
https://finance.yahoo.com/news/bioelectronics-corporation-announces-publication-canine-124500399.html
Vagus Nerve Patent Application Filing RecoveryRx
https://www.newmediawire.com/news/bioelectronics-corporation-announces-utility-patent-application-filing-7075138
________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs
7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------------
Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!
National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........
Context/Background:
Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.
Objective/Purpose:
The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.
Results:
An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.
Ranking:
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].
Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:
1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.
2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.
https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf
___________________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recoverry
rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
___________________________________________________________
Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://www.instagram.com/skymedicalsupply/p/C6J0wXQCGLF/
___________________________________________________________
Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091
_________________________________________________________
Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical
https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
__________________________________________________________________
Chairman Updates Investors
Outlines Sales Activities, Clinical Trials, and a potential legal Action Against MundiPharma
FREDERICK, MD. October 16, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire
https://www.facebook.com/BioElectronics/
BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST
https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________
Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate
https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html
____________________________________________________________
CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid
=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI
____________________________________________
ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:
http://actipatch.com 📷
No More Dangerous, Addictive or Expensive Drugs.
https://twitter.com/ActiPatch/status/1752421581769363689?s=20
___________________________________________________________________
ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain
https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351
ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!
11/20/2023
Washington State poised to extend coverage for SCS
https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________
ActiPatch SA
February, 6 at 1:35 Am
Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief#BackPainRelief
https://www.facebook.com/watch/?v=1124676815379216
__________________________________________________________________
NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!
https://www.neuromodulation.org/news/closed-loop-04172023
_______________________________________________________________
ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at:
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep
https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351
___________________________________________________________
Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!
https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
ActiPatch SA
tnepdosrSo810ii
There's a champion inside all of us – don’t let chronic pain hold you back! If life is the #2024Olympics, then ActiPatch® is your #1 supporter. 💪
https://www.facebook.com/watch/?mibextid=oFDknk&v=1038405881014609&rdid=FMmcKKO2DsmHYISt
You might have thought chronic pain would be with you for life, but now there's something that can help. 🌟 Meet ActiPatch®: pain relief
https://www.facebook.com/watch/?mibextid=CYgPv5&v=909395761002533&rdid=cqiPcvFNpcuizRNh
SAI, Airway, KT, have all renewed their 'FDA Establishment Registration' to sell ActiPatch for 2025
Name .......................................................................... Reg # ... Year
AIRWAY SURGICAL APPLIANCES LTD. CANADA .... 9611956 2025
KT Health, LLC UT/USA .........................................3007282994 2025
SURGICAL APPLIANCE INDUSTRIES, INC. OH/USA 1511629 2025
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm ("PQY" product code)
_________________________________________________________
PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center
https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
----------------------------------------------------------------------------------------
BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers
Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.
Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00
https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ
https://link.springer.com/article/10.1007/s42399-020-00652-y
---------------------------------------------------------------------------------------------------
New product added
https://actipatch.com/buy-1
BioElectronics’ pulsed shortwave therapy device
is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------------
Top5-USA.co
Top 5 Actipatch In The US
https://www.top5-usa.com/actipatch
------------------------------------------------------------------------------------------------------
RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.
https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-----------------------------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
"RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx."
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------
Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy https://vetphysiodevon.com/vet-recovery-rxdevice which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
----------------------------------------------------------------------------------------------------------
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$[
--------------------------------------------------------------------------------------------------------
From 3331:
WHICH CATALYST WILL BE FIRST?
:
1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.
100 VA Hospitals:
Conservatively assume each hospital orders 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.
Using profit = $20 mil and P/E = 100:
PPS = .08!
Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = .25 to $1?).
ADDITIONAL CATALYST:
Here are some additional numbers using Taiwan as a catalyst, using beacham's conservative numbers of 1% market penetration w/$10 profit/unit yields $43 million revenue:
$3 million = break even, cash flow positive: pps = .01.
Each additional $2.5 million/year should result in an additional .01 increase in pps (P/E = 100).
For revenue = $43 million, profit = $40 million (and applying the tax loss carryforward), resulting pps =
.16 (P/E = 100)
.32 (P/E = 200)
.48 (P/E = 300)
However, there are several factors that indicate this estimate might be extremely conservative, such as:
1) Taiwan appears to be using the RecoveryRx (requires doctor approval) version of Actipatch (OTC), which would have a higher profit than $10/unit.
2) market penetration will likely be higher than 1%.
Therefore, a case could be made for increasing the above estimates 10-fold or more (although tax would then need to be factored in). Now factor in the VA, veterinary, and other rumored contracts (if they materialize), and you're taking some serious money!
ANOTHER BIEL VALUATION MEASURE: QUBT hit $27/share recently, even though their revenue last year ($358k) was half that of BIEL ($715k). Accounting for the difference in outstanding shares (25 bil vs 100 mil), BIEL pps = .10 is the equivalent valuation to QUBT = $27/share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175566191
Trying to find signs of life!
https://beprepared365.co.za/products/2/actipatch
They have no choice...there's no money!
Post of the month. Friendly BIEL insiders.
‘Nuff said!
Those "insiders" have been rolling over their loans rather than demanding repayment of their convertible loans.
Those "insiders" have been rolling over their loans rather than demanding repayment of their convertible loans.
IMO, they still see a path to success for BIEL.
The last dilution via loan conversion was January 2022 by St John's, who started making new loans with the proceeds of that conversion in February 2022. Zero dilution in 2023 and 2024. All maturing loans were rolled over for another 2 years.
Such a refreshing BIEL post. Very refreshing!
Thanks srin. As always!!!
BUY $BIEL$
The total cost to secure the average 510K clearance is $30 million
Biel has five 510k Clearances completed for $40 million. Bargain of the century!!
K022404 - For the treatment of edema following Blepharoplasty (eyelid surgery)
K152432 - Adjunctive treatment of musculoskeletal pain related to: plantar fasciitis of the heel
K152432 - Adjunctive treatment of musculoskeletal pain related to: osteoarthritis of the knee
K190251 - Adjunctive treatment of postoperative pain
K192234 - Adjunctive treatment of musculoskeletal pain (every muscle, joint, bone, tendon, and ligament in the body)
I think I had a stroke reading that.... WTF
AI SUGGESTION FOR A TIK TOK MARKETING CAMPAIGN:
TikTok is the perfect stage for a product like ActiPatch—it thrives on stories, transformations, and just the right dash of humor. To optimize your “Feel It. Forget It.” campaign, we’ll need to lean into TikTok’s strengths: short-form video, trending audio, relatable narratives, and creator-led content. Here’s how to turn scrolls into conversions:
Let’s build out a storyboard for a TikTok video that could kick off the “Feel It. Forget It.” campaign and inspire UGC (user-generated content). We’ll combine humor, relatability, and a glow-up moment using a trending sound.
🎥 Storyboard: “Forgot the Pain” Skit
Title: "POV: I Forgot I Had Back Pain" Length: 15–30 seconds Sound: Use a trending audio—perhaps a remix of “I’m Good (Blue)” or any sound that's gaining traction via TikTok Creative Center.
Scene 1: The Struggle (Before)
[0–5s] A person hunches over, grimacing while trying to pick up laundry or reach their toes. Caption: “Me trying to adult with back pain 😩”
Scene 2: Introducing ActiPatch
[5–7s] They slap on the ActiPatch dramatically like a hero suiting up. Sound effect: Power-up noise or comic-style “BOOM!”
Scene 3: The Glow-Up (After)
[8–15s] Cut to them suddenly dancing, running, or even dramatically flipping pancakes—life is thriving. Caption: “Me 5 minutes later after forgetting the pain existed 💅🕺” Overlay text: “#FeelItForgetIt #ActiPatchFlip”
Scene 4: Call to Action
[15–20s] Text overlay: “Show us your pain-free flip with #ActiPatchFlip 🌀” Link to TikTok Shop for instant purchase.
Let’s blow the lid off this campaign then! 🔥 Here’s a more advanced set of deliverables to supercharge your TikTok rollout for ActiPatch. Consider this your “Virality Acceleration Kit”:
🎬 3 More Scripted Video Concepts
1. “Pain-Free Plot Twist”
Scene: A person dramatically setting up pillows and heating pads like they’re prepping for war. Caption: “Back pain level: boss battle.”
Twist: Friend walks in, says “Why don’t you just use this?”—hands over ActiPatch.
Final Shot: Protagonist now on a hike, sipping iced coffee.
Hashtags: #PlotPatch #BackPainGlowUp
2. “Love Letter to My Lower Back”
Scene: User gazing dreamily into the distance with romantic music.
Voiceover: “To the one who stuck by me through Zoom calls, car rides, and couch naps—you deserve peace.”
Action: Applies ActiPatch. “This one’s for you.”
Caption: “Normalize loving your lower back 💌”
3. “Boomer Reacts to TikTok Slang… Pain-Free”
Scene: Gen Z user duets with their parent/grandparent using ActiPatch.
Dialog: “No cap?” “No pain either!”
Funny moment: Elder breaks out into a dance.
Tagline: “ActiPatch: So effective even your dad might go viral.”
🧠 Influencer Outreach Template (Email/DM)
Subject: Let’s Make Pain Relief Go Viral 🔥 #ActiPatchFlip
Hey [Name],
We’re working with ActiPatch to redefine what pain relief looks like—and we think your voice would make it unforgettable.
The concept: Real people sharing their glow-ups, skits, and chaotic-but-relatable pain journeys. Think POVs, before/afters, or your own remix of our animated “Pain Gremlin.” We’d love you to put your spin on it!
Let me know if you're down to collab and we’ll send you everything you need (plus a surprise 👀).
Cheers,
[Your Name / Brand Contact]
🖼️ Visual Concepts for Creatives
Style: Bold, casual fonts (like Outfit or Anton), bright color blocks (lavender, coral, mint), and expressive face close-ups.
Animated Assets: Reusable stickers like “Pain Gremlin defeated,” “5 min post-patch,” or floating ActiPatch power symbols.
On-Screen Text: Use kinetic text synced with beats of trending audio for punchlines.
Juneteenth National Independence Day.
https://www.nyse.com/markets/hours-calendars
Are markets closed today because of holiday???
It could cure cancer, make me handsome, and make me lose 30 lbs.... if it does not sell, who cares?
art I also bought the Don Joy back brace & it works great but the new Bioelectronic back unit is easier to use & not as bulky allowing you to place the Actipatch over the area of your back pain ( for info ONLY I am not a PAID Pumper for Bioelectronic's Corporation, just a happy shareholder)!
Oh OK. I bought the back brace holder from DONJOY years ago and the velcro doesn't hold anymore. So I just tape mine on my back without the brace almost every night for sleeping. I have stated here for years that it helps me. That has NEVER been my gripe!
No art I am talking about a Back holder for use with an Actipatch - You must ADD an Actipatch to the Back Brace Holder!
It's also available 'ON SALE' on the KT TAPE website for $9.95. Has been for sometime now.
https://www.kttape.com/collections/kt-tape-products/products/kt-recovery-wave
If any posters have lower back pain you MUST see a new inexpensive product by Bioelectronics Corporation - The Back Wrap with Velcro Holders (Only $9.99 & free shipping)!!!!! From Bioelectronics website.
It does work! I use it also. That is not the issue many have here about this company, as an investment. But since it works, who is to blame for it not selling!? And who is to blame for investors absorbing a sorry triple zero stock price? Bashers are not just bashing because they think the product does not work. There are SO MANY other negatives to find that have occurred over the years that undoubtedly deserve the negative posting.
PS. And another one (makes 3, I have counted) who are blocking me from seeing their posts. Wonder why?
PSS. And your private messages to me have been duly noted!!
I am not here to replace anyone. I am here because I have followed this for years and have seen all this amateur leadership run company act like a typical PINK SHEET (scam?) company. The embarrassing stock promotion videos -- the declaring of deals made that never occurred - the CEO's immature arguing with stockholders on Facebook - the self serving 'family' loan to stock deal - the stopping of quarterly reports to their stockholders - the stopping of official PR's to the 'market'. -- ETC ETC
As long as the same ones keep pumping this, as they have all the while as the stock price crashes down here near ROCK BOTTOM, I will be pointing with factual numbers of WHY this is trading at and near ROCK BOTTOM and why that cheering of a CEO and praise of a never profitable company is a joke and just mindless pumping.
Over 20 years of never profitable!! ----and we hear: "GO BIEL - GO KELLY"! --- LOL!!!
Not always.....but usually the good guys end up winning. Biel is certainly one of the good guys. Like most longs...I'm waiting this out. My big gripe about Biel is their unwillingness to routinely update shareholders. We deserve better! There are plenty of people going to bat for Biel on this board without sufficient ammunition. It's bewildering to say the least.
$TILLABELIEVER! I use the actipatch after having a rotator cuff surgery as well as for my meniscus tear. At 72 yrs young still running 10 minute miles and bench pressing 190lbs. I would just ask the bashers to try it before they condemn its benefit! IT WORKS AND THE MEDICAL PROFESSION KNOWS IT!!!!
$.10+
Money or no money......it has to wear one out being so negative about a product you know works so well. It's like a disservice to the world of pain sufferers. Go Actipatch!
Just maybe art has replaced ddls??????
>>>It looks to me BIEL outlasted DDLS.<<<
Yes it did ---- to the amount of over $40,000,000 in accumulated losses!
Was that a copy and paste post from YEARS ago? --- LOL!!
Note holders total over $13,000,000. RS a couple million($). The way this is sadly going, does anyone believe that they would not be thrilled to take a buyout for that amount, just to get out of this? Thus leaving the stockholders with nothing. But honestly, who would pay even that (about $16,000,000) for a company that has been LOSING money every year? I am sure that they would probably take whatever they could get, as they must know the obvious outcome of a business that can never show a profit and has accumulated losses of over $40,000,000 over their years in business.
Yeah it DOES seem that the stockholders are screwed.
It looks to me BIEL outlasted DDLS.
What happened?
BUY $BIEL$
Non-BIELievers will look back and say oh my gosh, way back when, I could have bought BIEL cheap cheap cheap.
‘Nuff said!
BUY $BIEL$
For those, who are, deliberately, "INFECTED" themselves with comprehension/thinking disability virus, a repeat post!!!!!
DR. OZ on Actipatch ( 10 years ago, go to 6:25 mark ), listen and weep!!!!!!!!
https://www.youtube.com/watch?v=qVvS2dC2-1s
Now, that Dr. Oz is Tsar.......BIEL...$$$$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!
-----------------------------------------------------------------------------
DonJoy Store
EME Replacement Device ( FSA / HSA APPROVED!!!!!!$$$$$$$ )
https://www.donjoystore.com/donjoyr-advantage-eme-replacement-device?srsltid=AfmBOoqJL5fv-Tkyjz7NmuwFnDcBi2nm4lqHTYznN6zlx5vaKarK8IsL
------------------------------------------------------------------------------
A new over-the-counter treatment for heel pain caused by plantar fasciitis has received clearance from the United States FDA.
https://www.footandankleps.com/blog/new-wearable-therapy-provides-heel-pain-treatment
--------------------------------------------------------------------------------
Actipatch Smart Insole -- NEW & IMPROVED!!!
https://unovita.com/products/smart-insoletm-heel-pain-relief?variant=47506240471349
https://shop.renovabiomed.it/it/prodotti/3402-soletta-e-fascia-smart-insole.html?sfnsn=wa
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------
RecoveryRx now available through prosthetics for pain management, ortho, PT
Veterans Health Administration
VA providers now have access to recently FDA-approved non-opioid, non-invasive pain management device through RecoveryRx. RecoveryRx produces an electromagnetic field at the point of pain that changes how cells communicate pain. Research, technical information and studies available at www.RecoveryRx.co. It is an amazing device, unlike TENS units, RecoveryRx reduces pain without any kind of electrical stimulation feeling for the veteran. The antenna lasts 30 days, all Ortho, pain management, and PT providers can work through prosthetics (RecoveryRx is on the FSS) to get these on their patients for feedback and widespread use at the VA.
https://www.reddit.com/r/VeteransAffairs/comments/1gxclby/recoveryrx_now_available_through_prosthetics_for/?utm_source=share&utm_medium=mweb3x&utm_name=mweb3xcss&utm_term=1&utm_content=share_button
__________________________________________________
No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( like LYING that he/she/it has ANY amount of shares in BIEL, PRETENDING to be shareholder........i can smell those from a mile away!!! ), did/will do any desired effect !!!!! We know they are watching BASHING work here, before the checks are being cut!!!
--------------------------------------------------------------------------------------------------------
Territory///Distributor////Products Distributed/// Website
Australia LMT ActiPatch RecoveryRx www.actipatch.com.au
Bangladesh Multiple Health Pharma ActiPatch
Bahrain STADA ActiPatch www.stada.com
Botswana Adcock Ingram ActiPatch www.actipatch.co.za
China CICD ActiPatch
Finland Kir Fix Oy ActiPatch www.kir-fix.fi
Iran Al Mutawafiqua Modern Drug ActiPatch
Ireland Inish Pharmacy ActiPatch www.inishpharmacy.com
Italy OneGlobe Bio ActiPatch/RecoveryRx www.oneglobebio.com
Jordan Al Mutawafiqua Modern Drug ActiPatch
Kuwait Modern Development ActiPatch/RRx www.mdmedical.co
Lebanon Al Mutawafiqua Modern Drug ActiPatch
Mexico Novro Med S.A. de C.V. RecoveryRx https://globaltech.com.mx/
Oman Modern Development ActiPatch/RRx www.mdmedical.co
Qatar Modern Development ActiPatch/RRx www.mdmedical.co
Saudi Arabia STADA ActiPatch www.stada.com
Spain Acuna Fombona ActiPatch www.acuna-fombona.com
Spain PRIM Group RecoveryRx www.prim.es
South Africa Adcock Ingram ActiPatch www.actipatch.co.za
Sweden Swedish Healthcare Academy ActiPatch www.actipatch.se
Taiwan Aphrodite Bio-Medical Technology ActiPatch www.abmt.com.tw
UAE Modern Development RecoveryRx www.mdmedical.co
United Kingdom Chemist4u ActiPatch www.chemist-4-u.com/
United States BioElectronics Corp RecoveryRx www.recoveryrx.co/
United States DonJoy DonJoy Advantage www.donjoyperformance.com
Yemen Al Mutawafiqua Modern Drug ActiPatch
https://www.bielcorp.com/distributors/
-------------------------------------------------------------------------------------------------------
From 3331:
BIEL 2025 - GONNA RUN!
pps > .001 after management drops some positive hint(s) - Golden Cross (already achieved) and Blue Sky Breakout gets technicians/chartists attention and pps out of the trips;
pps > .01 after management drops positive hint(s) convincing investors that break even cash flow positive (annual rev = $1.5 mil) will be achieved, along with the momentum from a 2021 like OTC run (Reddit crowd takes notice);
pps > .04 after pr indicates annual revs from Taiwan (in progress) can be valued at $10 mil;
pps > .08 after pr indicates annual revs from VA (in progress) can be valued at $10 mil;
pps > .12 after pr indicates annual revs from RecoveryRx Veterinary (pending) can be valued at $10 mil;
pps > .16 after pr indicates annual revs from new contracts (distributors, partners, etc.) can be valued at $10 mil;
pps > $1 (2026 - 2027)after loans are paid off and a stock buyback program is initiated.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175652979
-------------------------------------------------------------------------------------------------------
ATTENTION all the Respected, Smart, Intelligent Investors !!!!!!! Do your OWN, INTELLIGENT, THOROUGH DD, without ANY INFLUENCE FROM KNOWN PAID BASHERS / PUMPERS / LIARS / MANIPULAYTORS / MISINFORMERS !!!!!!!!! Make sure, if you decide to invest ( and to decide you MUST !! ) :
#1 -- Don't put all the money you are willing to invest in one basket ( buy only one stock ), be diverse......VERY IMPORTANT -- Do your OWN, INTELLIGENT DD !!!!!!!!!!!!!!!!
#2 -- If you decide/willing to buy BIEL shares, know, that this is a HIGH RETURN / HIGH LOSS RISK ratio, but a MIRACLE PRODUCT ( ACTIPATCH ) is the key !!!!
#3 -- if you decide/willing to buy BIEL shares, invest only as much as you are willing
to loose, without being hurt, FINANCIALLY !!!!!!!!!!!!!!!!!
Good luck to all !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!! HEHEHE.
Here are the HARD FACTS about Bioelectronics corp ( BIEL ). below , backed by LINKS, NOT some made up LIES, BS WORD SALADS, SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS to DAMAGE one's IMAGE, to INFLUENCE POTENTIAL Investors to think negative about the Company's ( BIEL ) Future, to FALL for WORD SALADS of SCARE TACTICS, with an AGENDA !!!!!!!!!!!
BIEL$$$
------------------------------------------------------------------------------------------------------------
"If you’re looking for a powerful way to enhance your vitality, recover faster, and optimize your overall well-being, I highly recommend exploring PEMF therapy. It’s an investment in your health and a key component of my own personal journey towards peak performance.”
– Tony Robbins
Tony uses a high powered $25,000 PEMF machine but anyone can sample some of PEMF's capabilities with a $30 ActiPatch.
http://54.219.205.59/2023/07/17/the-energy-machine-that-powers-tony-robbins-exploring-the-transformative-power-of-pemf-therapy/
------------------------------------------------------------------------------------------------------------
Note, while NOPAIN ACT is a PREDICTION, YET, it is still a HARD FACT and VERY DOABLE!!!!!!!!
NOPAIN Act
Jan. 1, 2025
https://www.congress.gov/bill/117th-congress/house-bill/3259/text?s=2&r=1&q=%7B%22search%22%3A%22NOPAIN+ACT%22%7D
Just to highlight a few points::
(G) ACCESS TO NON-OPIOID TREATMENTS FOR PAIN.—
“(i) IN GENERAL.—
Notwithstanding any other provision of this subsection, with respect to a covered OPD service (or group of services) furnished on or after January 1, 2022, and before January 1, 2027, the Secretary shall not package, and shall make a separate payment as specified in clause (ii) for, a non-opioid treatment (as defined in clause (iii)) furnished as part of such service (or group of services).
“(ii) AMOUNT OF PAYMENT.—
The amount of the payment specified in this clause is, with respect to a non-opioid treatment that is—
“(I) a drug or biological product, the amount of payment for such drug or biological determined under section 1847A; or
II) a medical device, the amount of the hospital’s charges for the device, adjusted to cost.
“(iii) DEFINITION OF NON-OPIOID TREATMENT.
A ‘non-opioid treatment’ means—
“(I) a drug or biological product that is indicated to produce analgesia without acting upon the body’s opioid receptors; or
“(II) an implantable, reusable, or disposable medical device cleared or approved by the Administrator for Food and Drugs for the intended use of managing or treating pain;
that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed in a clinical trial or through data published in a peer-reviewed journal.”.>>>>
Ambulatory Surgical Center Payment System.—Section 1833(i)(2)(D) of the Social Security Act (42 U.S.C. 1395l(i)(2)(D)) is amended—
(1) by aligning the margins of clause (v) with the margins of clause (iv);
(2) by redesignating clause (vi) as clause (vii); and
(3) by inserting after clause (v) the following new clause:
“(vi) In the case of surgical services furnished on or after January 1, 2022, and before January 1, 2027, the payment system described in clause (i) shall provide, in a budget-neutral manner, for a separate payment for a non-opioid treatment (as defined in clause (iii) of subsection (t)(16)(G)) furnished as part of such services in the amount specified in clause (ii) of such subsection.”.
(c) Evaluation Of Therapeutic Services For Pain Management.—
1) REPORT TO CONGRESS.—
Not later than 1 year after the date of the enactment of this Act, the Secretary of Health and Human Services (in this subsection referred to as the “Secretary”), acting through the Administrator of the Centers for Medicare & Medicaid Services, shall submit to Congress a report identifying—
(A) limitations, gaps, barriers to access, or deficits in Medicare coverage or reimbursement for restorative therapies, behavioral approaches, and complementary and integrative health services that are identified in the Pain Management Best Practices Inter-Agency Task Force Report and that have demonstrated the ability to replace or reduce opioid consumption; and
(B) recommendations to address the limitations, gaps, barriers to access, or deficits identified under subparagraph (A) to improve Medicare coverage and reimbursement for such therapies, approaches, and services.>>>>
(2) PUBLIC CONSULTATION
.—In developing the report described in paragraph (1), the Secretary shall consult with relevant stakeholders as determined appropriate by the Secretary.
(3) EXCLUSIVE TREATMENT.
—Any drug, biological product, or medical device that is a non-opioid treatment (as defined in section 1833(t)(16)(G)(iii) of the Social Security Act, as added by subsection (a)) shall not be considered a therapeutic service for the purpose of the report described in paragraph (1).
___________________________________________________________________
The Pain Relief Therapy Market is characterized by a diverse competitive landscape, with several leading companies influencing market trends and driving innovation. Notable players include:
Stimwave: Specializes in innovative neuromodulation devices designed for chronic pain management, focusing on minimally invasive procedures to enhance patient outcomes.
Merk & co: A global leader in pharmaceutical products, Merck is actively involved in developing new analgesics and expanding its portfolio to address unmet medical needs in pain management.
Sanofi: Known for its wide range of pharmaceutical products, Sanofi is committed to advancing pain relief therapies through research and strategic partnerships.
Endo Pharmaceuticals.: Focused on pain management solutions, Endo is leveraging its expertise to develop unique formulations that cater to varying patient needs.
Calmare Therapeutics: Recognized for its innovative non-invasive pain relief technology, Calmare Therapeutics is pioneering new approaches to chronic pain treatment.
Johnson & Johnson: A key player in the healthcare sector, Johnson & Johnson is expanding its pain relief offerings through a combination of product innovation and strategic acquisitions.
Abbott: Engaged in developing advanced pain relief systems, Abbott is at the forefront of creating integrated solutions that combine medical devices and pharmaceuticals.
Allergan: Known for its aesthetic and therapeutic products, Allergan is also exploring pain relief therapies, particularly in the realm of nerve block techniques.
Beiersdorf: While primarily recognized for its skincare products, Beiersdorf is venturing into the pain relief market with topical analgesics and other innovative solutions.
Hisamitsu.: A leader in transdermal drug delivery systems, Hisamitsu is focused on developing patch-based pain relief solutions.
UltraCare Pro: Specializes in therapeutic modalities that enhance pain management through non-invasive techniques.
Iskra Medical.: Develops medical devices that facilitate pain relief, particularly in physiotherapy and rehabilitation settings.
Bioelectronics Corp: Innovates in the field of electroceuticals, offering non-drug solutions for pain management .
Medline : A major player in the healthcare supply chain, Medline is expanding its product offerings to include pain management solutions.
Pfizer: Actively involved in researching and developing new pain relief medications to address chronic pain issues.
Each of these companies plays a vital role in shaping the Pain Relief Therapy Market through product innovations, market expansions, and strategic partnerships, contributing to the overall growth and development of the sector.
Moreover, consumer awareness regarding pain management options is on the rise. Patients are becoming more informed about their choices, leading to increased demand for customized solutions that cater to individual needs. This trend is prompting companies to focus on product customization and the development of tailored therapies.
Emerging technologies, such as wearable devices and Internet of Things (IoT) solutions, are also shaping the future of the Pain Relief Therapy Market. These innovations allow for continuous monitoring of patients' conditions, enabling timely interventions and adjustments to treatment plans based on real-time data.
https://www.openpr.com/news/3785778/pain-relief-therapy-market-industry-dynamics-and-contributions
__________________________________________________________________
CY 2025 Medicare Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System Proposed Rule (CMS 1809-P)
“Access to Non-Opioid Treatments for Pain Relief
…We are proposing that seven drugs and one device qualify as non-opioid treatments for pain relief, and we propose these products be paid separately in both the HOPD and ASC settings starting in CY 2025…”
https://www.cms.gov/newsroom/fact-sheets/cy-2025-medicare-hospital-outpatient-prospective-payment-system-and-ambulatory-surgical-center
CONCLUSION
"The medical device market is poised for significant growth across all major regions, driven by technological advancements, increasing healthcare spending, and a global focus on improving healthcare outcomes. London and the UK continue to position themselves as leaders in medical device innovation, while Europe remains a regulatory-driven but stable market. Asia offers the most dynamic growth opportunities, with countries like China and India playing pivotal roles. Meanwhile, the USA maintains its dominance as the largest medical device market, supported by advanced R&D and regulatory frameworks. Investors looking to capitalize on these trends should consider region-specific opportunities, keeping an eye on the evolving regulatory landscapes and technological innovations shaping the industry."
https://iotworldmagazine.com/2024/09/05/2420/a-review-of-medical-device-market-size-reports-2024-2025-in-london-u-europe-asia-and-usa-focused-on-growth-forecast-and-segments
REFERENCES
Fortune Business Insights: https://www.fortunebusinessinsights.com/
MarketsandMarkets: https://www.marketsandmarkets.com/
Mordor Intelligence: https://www.mordorintelligence.com/
Gov.UK: https://www.gov.uk/
GlobalData: https://www.globaldata.com/
TechNavio: https://www.technavio.com/
Statista: https://www.statista.com/
Emergo: https://www.emergobyul.com/
Frost & Sullivan: https://www.frost.com/
Allied Market Research: https://www.alliedmarketresearch.com/
BMI Research: https://www.bmiresearch.com/
IBISWorld: https://www.ibisworld.com/
McKinsey: https://www.mckinsey.com/
Grand View Research: https://www.grandviewresearch.com/
----------------------------------
Globe Newswire via NewsMeiaWire
Sree Koneru, PhD Joins the Board of BioElectronics Corporation
FREDERICK, MD December 3, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC:
BIEL a developer of medical technology products, today announces that Sree Koneru, PhD, will join its Board of Directors, effective December 3, 2024. Upon Dr. Koneru’s appointment, the Board will consist of three members, including Kelly Whelan, President of BioElectronics, and its Chairman, Richard Staelin, PhD.
https://www.facebook.com/story.php?story_fbid=1120914580039912&id=100063641406505
___________________________________________________
Nasdaq news:
BioElectronics Corporation Announces Utility Patent Application Filing
PUBLISHED
MAY 21, 2024 8:09AM EDT
Non-Invasive Device Addresses the Treatment of Chronic Inflammation
FREDERICK, MD - (NewMediaWire) - May 21, 2024 - BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announces the filing of a new USPTO utility patent application addressing the treatment of chronic inflammation. This patent application, numbered 18/667,971, was a collaborative effort of John Martinez, Kenneth McLeod, PhD, and Richard Staelin, PhD. It outlines methods, systems, apparatuses, and devices that modify the immune response through non-invasive stimulation of the vagal nerves. The application draws from the results of a recently completed double-blind, placebo-controlled, canine study, published in Veterinary Medicine and Science which demonstrated that Pulsed Short Wave Therapy (PSWT) Technology applied to the vagal nerves of dogs diagnosed with osteoarthritis resulted in significant reductions in systemic discomfort.
https://www.nasdaq.com/press-release/bioelectronics-corporation-announces-utility-patent-application-filing-2024-05-21
____________________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
Pulsed Electromagnetic Field Enhances Caffeic Acid Phenethyl Ester-induced Death of MCF-7 Breast Cancer Cells
https://pubmed.ncbi.nlm.nih.gov/38821617/
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
ORTHOALLIANS
RecoverRX!!
https://orthoalliance.com/optimal-recovery/
MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
___________________________________________________________
News
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
Staff Writer February 26, 2024
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info @newbie00 to request sample products.
Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
Tanya Ella Sprunks, Kenneth J. McLeod, Richard Staelin
First published: 22 March 2024 https://doi.org/10.1002/vms3.1408
Sree Koneru and Jack Merrifield contributed equally to this study.
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
Ortho Alliance, 11 Orthopedic Surgery Centers, 'Optimal Recovery' with Pre/Post-Op RecoveryRx
https://orthoalliance.com/optimal-recovery/
Smart Approach Recovery
https://recoveryrx.carrd.co/
Kelly Cove Mobility
https://youtu.be/jljs7QPX7KE
RecoveryRx Veterinary
https://rrxvet.carrd.co/
TES Veterinary Physiotherapist
https://vetphysiodevon.com/vet-recovery-rx
Actipatch Taiwan
https://www.actipatchtw.com/general-1
Actipatch Sweden
https://rehabat.se/products/actipatch-mot-muskel-och-ledsmarta-och-kna-och-ryggsmarta
Actipatch Italy
https://alaction.it/
Actipatch Bulgaria
https://actipatch.bg/
Actipatch Finland
https://www.facebook.com/watch/?mibextid=SphRi8&v=1026096241843857&rdid=0EAph2C6CZ4xryHY
ActiPatch STADA
https://www.linkedin.com/posts/kelly-whelan-5ba88115_distribution-painrelief-stada-ugcPost-7274483449602748417-__ZB/
BIEL announces publication of Canine OA Study
https://finance.yahoo.com/news/bioelectronics-corporation-announces-publication-canine-124500399.html
Vagus Nerve Patent Application Filing RecoveryRx
https://www.newmediawire.com/news/bioelectronics-corporation-announces-utility-patent-application-filing-7075138
________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
" RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx. "
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs
7 Well-Being Benefits of PEMF Therapy
https://www.samuelmaddockhealth.com/pemf/7-well-being-benefits-of-pemf-therapy
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------------
Actipatch ranked #1 in NASA Electromagnetic Pain Relief/Blocking: Feasibility Assessment !!!!!!!!
National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
( pages 14, 15 )........
Context/Background:
Astronauts use pharmaceuticals during spaceflight to manage acute and chronic pain, but use of analgesics will have drawbacks for exploration-class missions because the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of action that either stimulate or suppress neural activity in the central nervous system or peripheral nerves.
Objective/Purpose:
The available literature was reviewed and FDA-approved pain treatments (both pharmacological and non-pharmacological), as well as those currently under development, were assessed for their suitability for use in exploration class spaceflight missions.
Results:
An overwhelming majority of the literature focuses on the treatment of chronic rather than acute pain because it is assumed that acute pain only rarely fails to resolve and instead transitions into chronic pain when the central nervous system becomes hypersensitized. The available electromagnetic devices marketed for pain treatment have varying levels of
invasiveness, use different mechanisms of action, and have demonstrated varying efficacy when evaluated scientifically. A truly noninvasive, highly efficient device is desired for use during spaceflight. One portable, self-contained, FDA-approved device was identified that, from preliminarily assessment, best met these criteria; the device noninvasively applies pulsed
shortwave therapy (PSWT) to modify pain signals from peripheral nerves, however, the device has limited battery life and the effects are relatively non-selective in type of neural signal modified.
Ranking:
The treatment method ranked first in this review was pulsed
shortwave therapy (PSWT), a low-power RF (MHz range) transmitter operated adjacent to biological tissue at maximum output (saturation) to modulate peripheral nerve activity. ActiPatch is a very small wearable PSWT device that is FDA approved for “adjunctive treatment of musculoskeletal pain”
[Anwar-Deen 2020]. It is low cost, low power, and boasts 97% efficacy in reducing pain (85% over a 6-month period) [Staelin 2019]. The device can be secured to the body by physio tape and the area causing pain is bounded by the device’s ring. The device can be turned on and off, and the non-rechargeable battery is capable of 720 hours of operation
(one month continuous use). ActiPatch is sold OTC in local pharmacies for ~$30 [ActiPatch 2020].
Conclusions:
The information obtained in the execution of this review effort leads to 2 recommendations for forward work:
1. Tie into DoD and NIH research funding efforts to improve pain treatment: the NIH has a federal partners workgroup for their HEAL Initiative that could conceivably be joined by NASA, and the DoD CPMRP’s initial solicitation only recently completed so that program is young and potentially synergies could be identified with NASA.
2. Obtain an ActiPatch device for evaluation and determine whether it could be beneficial and adapted to spaceflight use.
https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf
___________________________________________________________
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recoverry
rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
___________________________________________________________
Skymedicalsupply
•skymedicalsupply's profile picture
Introducing the EME BACK WRAP with ActiPatch® Technology, a revolutionary pain relief solution for your back. This innovative wrap utilizes ActiPatch® technology, clinically proven to alleviate pain by regulating the activity of sensitized nerves and reducing abnormal pain signaling. With its ability to deliver 1,000 sensation-free electromagnetic pulses per second, this wrap offers effective relief for up to 720 hours.
https://www.instagram.com/skymedicalsupply/p/C6J0wXQCGLF/
___________________________________________________________
Welcome to the largest
health and beauty store in Europe! PromoFarma is the marketplace which groups the catalogues from more than 1.000 pharmacies and other sellers into one single website, selects the basket of products at the best price, collects the order from the selected pharmacies and delivers it wherever you want.
ActiPatch effective knee-pain relief !!!!!!!!
https://www.promofarma.com/en/actipatch-effective-knee-pain-relief-1pc/p-552091
_________________________________________________________
Accelerated recovery of post-operative dental implant patients using drug-free RecoveryRx.
Read the paper here:
https://lnkd.in/daQ4GRa
#painrelief #neuromodulation #fdacleared #drugfree #clinicallyproven #painmanagement #oralsurgery #dentalimplants #postsurgical
https://www.linkedin.com/posts/bioelectronics-corporation_painrelief-neuromodulation-fdacleared-activity-6778677760979152896-XQZ1
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
__________________________________________________________________
Chairman Updates Investors
Outlines Sales Activities, Clinical Trials, and a potential legal Action Against MundiPharma
FREDERICK, MD. October 16, 2024 -- (GLOBE NEWSWIRE) -- via NewMediaWire
https://www.facebook.com/BioElectronics/
BioElectronics Chairman Updates Investors
Thu, February 15, 2024 at 9:00 AM EST
https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
______________________________________________________________
Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate
https://www.prnewswire.com/news-releases/voices-for-non-opioid-choices-coalition-applauds-introduction-of-alternatives-to-pain-act-in-senate-302076547.html
____________________________________________________________
CHEMIST4u ( UK )
ActiPatch Muscle and Joint Pain Therapy Devices
https://www.chemist-4-u.com/brands/actipatch?fbclid
=IwAR21Sy7YpQYVw-otDE2ah9aPf-DNslt0jUw4xJMFcKxAXRyo_JkWNQ7TcYI
____________________________________________
ActiPatch is the drug-free solution for pain. It interrupts abnormal pain signaling in the nerves. You won't feel anything but relief. $$$ BACK GUARANTEE USA:
http://actipatch.com 📷
No More Dangerous, Addictive or Expensive Drugs.
https://twitter.com/ActiPatch/status/1752421581769363689?s=20
___________________________________________________________________
ActiPatch®
@ActiPatch
ActiPatch reaches deep into the painful area to provide real relief at the source. Can be used 24/7. You won't feel anything but PAIN RELIEF.
$$$ BACK GUARANTEE OFFER USA:
http://actipatch.com 📷 #neckpainrelief #techneckrelief #painrelief #neckarthritisrelief #neckpain
https://twitter.com/ActiPatch/status/1745131740358729994?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1745131740358729994%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351
ITS coming to BIEL $$$$$$$$$$$$$$$$$$$!!!!!!!!!!!!!!!!!!!!!!!!
11/20/2023
Washington State poised to extend coverage for SCS
https://www.neuromodulation.org/news/washington-state-poised-to-extend-coverage-for-scs
________________________________________________________________
ActiPatch SA
February, 6 at 1:35 Am
Struggling with chronic pain? 🤕 ActiPatch® pain-relief device is clinically proven to relieve muscle and joint pain!¹?³
✅ Ideal for arthritis, back pain, knee pain, fibromyalgia, and more.²
🔍 Targeted, long-lasting pain relief in just 2-3 hours.¹
🔋 Lasts up to 720 hours for continuous comfort.
🚀 Small & lightweight.¹ Say goodbye to bulky equipment!
Get back to feeling your best with ActiPatch®, available at Dis-Chem Pharmacies, Clicks and leading pharmacies nationwide.
#ActiPatch #DrugFree #PainRelief #PainManagement #ChronicPainManagement #JointPainRelief #SportsInjuryRelief#BackPainRelief
https://www.facebook.com/watch/?v=1124676815379216
__________________________________________________________________
NANS Advocacy Results in HCSC Adding Closed-Loop Spinal Cord Stimulation to Coverage!!
https://www.neuromodulation.org/news/closed-loop-04172023
_______________________________________________________________
ActiPatch®
@ActiPatch
Get the sleep you deserve with relief from ActiPatch! ActiPatch doesn't just put a band-aid on pain. It dives deep with its Pulsed Shortwave Therapy & takes on pain at its root for sustained relief! Order at:
http://actipatch.com FREE SHIPPING. #painmanagement #painfreesleep
https://twitter.com/ActiPatch/status/1737209416749887575?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1737209416749887575%7Ctwgr%5E811275876d36002daf58d004f9820350cd7adb08%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D173613351
___________________________________________________________
Chronic Pain, Fibromyalgia and Plantar Fasciitis Help --- ACTIPATCH!!!
https://www.facebook.com/groups/1795257327156301/?multi_permalinks=7709195185762456
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
_____________________________________________________________
ActiPatch SA
If tennis injuries are following you off the court, ActiPatch® can help lessen your downtime by serving up clinically proven joint and muscle pain relief!²,³
🎾 Drug free¹
🎾 Can be worn 24/7, even during physical activity and sweating¹
https://www.facebook.com/share/v/jdHfKoc7x7dB...tid=CYgPv5
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
ActiPatch SA
tnepdosrSo810ii
There's a champion inside all of us – don’t let chronic pain hold you back! If life is the #2024Olympics, then ActiPatch® is your #1 supporter. 💪
https://www.facebook.com/watch/?mibextid=oFDknk&v=1038405881014609&rdid=FMmcKKO2DsmHYISt
You might have thought chronic pain would be with you for life, but now there's something that can help. 🌟 Meet ActiPatch®: pain relief
https://www.facebook.com/watch/?mibextid=CYgPv5&v=909395761002533&rdid=cqiPcvFNpcuizRNh
SAI, Airway, KT, have all renewed their 'FDA Establishment Registration' to sell ActiPatch for 2025
Name .......................................................................... Reg # ... Year
AIRWAY SURGICAL APPLIANCES LTD. CANADA .... 9611956 2025
KT Health, LLC UT/USA .........................................3007282994 2025
SURGICAL APPLIANCE INDUSTRIES, INC. OH/USA 1511629 2025
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfrl/rl.cfm ("PQY" product code)
_________________________________________________________
PEMF Alzheimer’s Treatment Pilot Underway at Hackensack University Medical Center
https://www.hackensackmeridianhealth.org/en/info/geriatrics/evoke-trial
BioElectronics’ pulsed shortwave therapy device is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
----------------------------------------------------------------------------------------
BioElectronics Corporation’s Post
View organization page for BioElectronics Corporation
BioElectronics Corporation
3,331 followers
Both NSAID therapy and neuromodulation therapy using PSWT resulted in statistically and clinically important reductions in pain level and improvement in functionality associated with cervical osteoarthritis, when used for 4 weeks. However, the PSWT intervention demonstrated superior improvements in all outcome measures when compared to the etoricoxib therapy arm, including patient satisfaction rating and decreased use of rescue pain medication. These results suggest that neuromodulation using PSWT may be a superior pain treatment option, when compared to COX-2 NSAIDS for neck osteoarthritis, and as well, represents a non-invasive, non-pharmacologic treatment option.
Product samples are available to licensed medical care providers in the USA. Request via email - info[ @newbie00
https://www.linkedin.com/posts/bioelectronics-corporation_pulsed-shortwave-therapy-in-cervical-osteoarthritis-activity-7138985310968795136-SRFJ
https://link.springer.com/article/10.1007/s42399-020-00652-y
---------------------------------------------------------------------------------------------------
New product added
https://actipatch.com/buy-1
BioElectronics’ pulsed shortwave therapy device
is effective for limb pain: study says
https://www.nsmedicaldevices.com/news/bioelectronics-pulsed-shortwave-therapy-device/
MD Medical
MD Medical is the fastest growing medical company in kuwait.
SIster Company @socheck_kuwait
Kuwait, Hawally Governorate, Salmiya, Block 2, Abdullah Bin Masoud Street, Al-Ras Tower, Floor 3, Office No.B3, Kuwait City 13091
https://www.instagram.com/mdmedicalco/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------------
Top5-USA.co
Top 5 Actipatch In The US
https://www.top5-usa.com/actipatch
------------------------------------------------------------------------------------------------------
RecoveryRX
BOSTON ORTHOPEDIC & RESPIRATORY EQUIPMENT, LLC.
https://www.bostonorthoresp.com/214-4_p_10155.html?referrer=rss
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-----------------------------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
"RecoveryRx repairs and regenerates damaged cells by reducing pain and inflammation and accelerating blood flow. Whereas, TENS is only blocking pain signals and has no healing effect. The major difference between the two is that a TENS unit is a short term solution that “turns off” the pain signal but CANNOT perform the function of repairing damaged tissue like RecoveryRx."
https://www.linkedin.com/posts/lauren-jarman-380a801a9_clinicallyproven-fdacleared-noninvasive-activity-7051200138563735553-Q9Zs
A SDVOSB Owned Exclusive Provider of RecoveryRx for VA ( Veterans ) Hospitals!!!!
https://veteranrecovery.org/
Veterans, connect with us to learn more about RecoveryRx®
New PAIN RELIEF TECHNOLOGY at the push of a button!!!
https://kellycovemobility.com/rrx/
BIEL$$$
RecoveryRX Major General Livingston, a Medal of Honor recipient, who had 6 operations for back, does a fantastic job describing his experience with RecoveryRx Pain Relief!!!!!
https://youtu.be/jljs7QPX7KE
"Literally, there are so many benefits to a regular PEMF therapy session. Research by NASA and other bodies has found that PEMF therapy can deliver the following results:
Better circulation
Pain reduction
Improved muscle relaxation and performance
Decreased inflammation and swelling
Improved oxygenation in tissue
Enhanced cellular repair and recovery
Improved immune system
Better sleep "
https://higherdose.com/blogs/news/8-benefits-of-pemf-therapy?psafe_param=1&tw_source=google&tw_adid=634407957086&tw_campaign=18892036948&gad=1&gclid=CjwKCAjw44mlBhAQEiwAqP3eVqY1HlussPIpcLNFP0O10gqhWUrMI0VdqtspfI3FlKHqC0HkjB_OkBoCc08QAvD_BwE
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------------
Watch till the end!
https://www.instagram.com/reel/Cvq8j0bILP4/?igshid=MzRlODBiNWFlZA==
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
-------------------------------------------------------------------------------------
This is just a few FACTS to help with INTELLIGENT DD and to INVEST in BIEL, which, i/we agree with this post worth a reasonable investment:
(https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172266874;; )
INTRODUCING
RecoveryRx Veterinary
Drug-Free Pain Relief Device
For Indoor and Outdoor Pets
https://rrxvet.carrd.co/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
Vet Recovery RX
"An innovation in drug-free pain and edema management. RecoveryRx is a class II, USA FDA-cleared, non-thermal shortwave therapy device which utilizes radio-frequency electromagnetic energy to modulate nerve activity"
https://vetphysiodevon.com/vet-recovery-rx#:~:text=An%20innovation%20in%20drug%2Dfree,energy%20to%20modulate%20nerve%20activity
Alpha Animal Rehab and Fitness is at Alpha Animal Rehab and Fitness.
Exciting news at #AARF—we have two new products to support your pup’s health and recovery: RecoveryRX and YuMove! 🐾 RecoveryRX is a wearable device that uses low-level electromagnetic therapy to help reduce pain and inflammation, perfect for dogs recovering from surgery or dealing with chronic conditions.
https://www.facebook.com/story.php?story_fbid=463227680005342&id=100089543403668&mibextid=xfxF2i&rdid=KBLw46cEZ1egeIst
PEMF Ring is Saving a 14 Year Old Labrador
https://therapyproducts.net/pemf-ring-is-saving-a-14-year-old-labrador/
Alpha Animal Rehabilitation and Fitness | NJ
Pet Service
Certified Canine Rehab Therapists helping pets with conditions/injuries/post surgery to manage pain and recover holistically through Physical Therapy
316 3rd Ave, Alpha, New Jersey 08865
https://investorshangout.com/images/MYImages/519436370_Screenshot_27-8-2024_7119_www.instagram.com.jpeg
"As the sole UK and European distributor of Recovery RX Veterinary, Tanya Sprunks offers advanced long-lasting pain relief for pets using Electromagnetic Pulse Therapy. She operates several successful clinics across Devon, focusing on Veterinary Physiotherapy."
https://www.glebevets.co.uk/services/physiotherapy/
----------------------------------------------------------------------------------------------------------
Old sports injury trying to bench you from the summer fun? 🌞🌊 Get back in there with ActiPatch® on your team! 🌟
✅ Pain relief can be felt after just 2-3 hours
✅ Safe to use during regular physical activity and during sweating
✅ Sensation-free
✅ 720 hours targeted pain relief
https://www.facebook.com/story.php?story_fbid=902558151905395&id=100064536555745&mibextid=qi2Omg&rdid=URPi9d5OMiBVi0WC
Once, pay ATTENTION Everyone -- NOT if, imo, NHL, NFL, NBA, WBA, MLB, PGA, Lacrosse, etc...... adopts Actipatch as a must protocol, after all those HITS, CHECKS, TRIPS, LIGAMENT PULLS/RIPS, etc.......Possibilities are ENDLESS !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
WOW!!!! Now Actipatch on the GYM's agenda!!! Nice Plug on GymProTips !!!!!!!!
ActiPatch® technology, your best ally
ActiPatch® is a therapeutic micro- device for personal use that works by means of electromagnetic fields that act at the source of pain. They stimulate cells that have been damaged and reduce inflammation of muscles and joints.
https://gymprotips.com/tips-to-speed-recovery-from-injury/
BIEL $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
----------------------------------------------------------------------------------------------------
From 3331:
WHICH CATALYST WILL BE FIRST?
:
1000 Veterinarian Clinics (USA):
Conservatively assume each office orders 10/mo. @ $100 each for BIEL (Vet sells for $200, a bargain compared to Assisi):
1000 x 100 x 10 x 12 = $12,000,000 rev/year.
100 VA Hospitals:
Conservatively assume each hospital orders 100 RecoveryRx per month ($100 each for BIEL):
100 x 100 x 100 x 12 = $12,000,000 rev/year.
Using profit = $20 mil and P/E = 100:
PPS = .08!
Additional revenue could be generated from new FDA clearances, vagus nerve patent, NPA, UK/Australia contract rumor, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (pps = .25 to $1?).
ADDITIONAL CATALYST:
Here are some additional numbers using Taiwan as a catalyst, using beacham's conservative numbers of 1% market penetration w/$10 profit/unit yields $43 million revenue:
$3 million = break even, cash flow positive: pps = .01.
Each additional $2.5 million/year should result in an additional .01 increase in pps (P/E = 100).
For revenue = $43 million, profit = $40 million (and applying the tax loss carryforward), resulting pps =
.16 (P/E = 100)
.32 (P/E = 200)
.48 (P/E = 300)
However, there are several factors that indicate this estimate might be extremely conservative, such as:
1) Taiwan appears to be using the RecoveryRx (requires doctor approval) version of Actipatch (OTC), which would have a higher profit than $10/unit.
2) market penetration will likely be higher than 1%.
Therefore, a case could be made for increasing the above estimates 10-fold or more (although tax would then need to be factored in). Now factor in the VA, veterinary, and other rumored contracts (if they materialize), and you're taking some serious money!
ANOTHER BIEL VALUATION MEASURE: QUBT hit $27/share recently, even though their revenue last year ($358k) was half that of BIEL ($715k). Accounting for the difference in outstanding shares (25 bil vs 100 mil), BIEL pps = .10 is the equivalent valuation to QUBT = $27/share.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175566191
Well, the suspension of quarterly reports and the complete lack of company information of any kind benefits the insiders and the debt holders. This allows those insiders to continue dumping shares a few hundred thousand (sometimes more) at a time on the uniformed public. By perpetuating the false possibility of a positive surprise, shares can be unloaded indefinitely. It could go on for months. In the end, of course, the debt holders will own the company by either debt conversion or bankruptcy. It doesn't matter whether share ownership has been for years or one day. The shareholders will receive nothing. Best of luck to the longs, but this can end no other way.
Hard to be a believer with inconsistency all over.
Followers
|
1097
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
341556
|
Created
|
05/18/05
|
Type
|
Free
|
Moderators misanthrope JustGoDeep GetSeriousOK toohot gimmee greenbacks |
PHOENIX, June 13, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire welcomed Andy Whelan, President of BioElectronics Corporation (OTC Pink:BIEL) ("the Company") back onto the "Stock Day" podcast. Andy spoke with Everett about their progress in the US market, UK market, the new product, the US FDA, and new distributors and potential partnership opportunities.
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch(R) Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx(R) Devices for chronic and post-operative wound care; Allay(R) Menstrual Pain Therapy. For more information, please visit http://www.bielcorp.com/
The Company is currently pursuing multiple US partnership opportunities that are partially contingent on additional FDA clearance for the treatment of musculoskeletal pain, back pain, knee pain, muscle, hip, carpal tunnel, etc. Whelan said,"Patience is key throughout this process. It's going as well as it can." Additionally, the Company anticipates solidifying deals with two new major distributors in the Asian and Eastern European markets.
The Company's product development and regulatory clearances are going well. Now, with pre-submission clearance, the 510(k) relief of musculoskeletal pain market clearance application will be filed by the end of June.
The US FDA has recently implemented an Innovation Program seeking "Breakthrough Devices" to Prevent and Treat Opioid Use Disorder. Opioids are routinely used for post-operative pain. Our United Kingdom ActiPatch User Registry accounts that 71% of opioid customers report a moderate (50%) to complete (100%) elimination in opioid medication use. The Company plans to submit its post-operative pain relief market clearance application into this program. The FDA's assistance, participation, and approval will provide credence and accelerate product market acceptance.
The Company has begun shipments of its new single box kinesiology tape product to be used for back, knee, hip, and muscles and joints in lieu of the back wrap, knee wrap and muscle and joint adhesives. The kinesiology tape is easier to use, reduces product costs, and retail shelf space requirements.
The Company is transitioning its United Kingdom over-the-counter sales and marketing from the front of the store to behind the counter to expand product availability from a few stores to all 14,000 pharmacies. Most pharmacies obtain daily product deliveries and most people in the UK qualify for free prescriptions.
Whelan is confident in the direction the Company is moving, and cites the unique nature of their products as a factor that helps the Company stand out in the global medical electronics industry. Whelan then said, "This is one busy little Company."
"Stock Day" host Everett Jolly stands by his assessment from his April interview with the company that the stock is very undervalued. BioElectronics Corporation trades on the OTC Pink market under the ticker symbol BIEL. Shares are currently selling at 0.0037, up over 100% since April.
For more details about the Company's recent FDA meetings, potential partnership opportunities, and attempts to combat the ongoing opioid crisis, follow the link below to hear the full interview.
https://upticknewswire.com/featured-interview-ceo-andrew-whelan-of-bioelectronics-corp-otc-pink-biel-3/ ;
About BioElectronics Corporation
BioElectronics develops and manufactures unique nonprescription affordable neuromodulation medical devices. The Company's technology platform is for the treatment of central sensitization, which is now widely accepted as the physiological explanation for many neurological disorders, and specifically chronic pain. Central sensitization is difficult, if not impossible, to address through pharmacotherapy without having a detrimental impact on normal physiologic function. Moreover, pharmacological and masking therapies (creams, heat patches, TENS etc.) have limited effectiveness for chronic pain due to their transient nature. BioElectronics' electromagnetic stimulation therapy has the distinct advantage of being safe, affordable, long lasting, and effective pain relief.
Contact: Paul Knopick, 940.262.3584, pknopick@eandecommunications.com
FREDERICK, MD., May 31, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed development of its same day surgical TOTAL Pathway program for joint replacements which includes BioElectronics medical devices. The program is being launched by B. Braun’s UK […]
FREDERICK, MD, May 29, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com reports that it has cancelled today’s scheduled US Food and Drug Administration meeting. “The FDA’s response to our questions, suggestions, and instructions are more than adequate for us to proceed with filing of the formal 510(k) Market Clearance Application,” stated Ian […]
FREDERICK, MD , May 11, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9th, 2018 with the US Food and Drug Administration (US FDA). The FDA’s Pre-Submission Program is designed to organize and give guidance and feedback on clinical data and what […]
FREDERICK, MD, May 02, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that two meetings have been scheduled with the US Food and Drug Administration (FDA) to seek expanded over-the-counter (OTC) clearances for their drug-free, wearable medical devices. The first meeting will take place on May 9th, 2018 to […]
PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) — Uptick Newswire was thrilled to have Keith Nalepka, VP of Marketing & Sales at BioElectronics (OTC Pink:BIEL) (“the Company”), return to the “Stock Day” podcast. The company has been working hard lately to expand the United Kingdom market with B. Braun in the surgical market and the product […]
FREDERICK, MD, March 19, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce the commencement of a clinical study investigating the efficacy of its RecoveryRx® device for postoperative pain management and recovery following total knee arthroplasty surgery. Currently there are 700,000 total knee replacement surgeries in the US alone and are projected to grow 673% to 3.5 million procedures per […]
PHOENIX, Jan. 22, 2018 (GLOBE NEWSWIRE) — The Uptick Newswire “Stock Day” podcast keeps investors up to date on the latest penny stock news by bringing transparency in the micro-cap side of the market. Connect with “Stock Day” and to over 600+ CEO interviews on the OTC, Pink Sheets and micro-cap news from around the world […]
FREDERICK, MD, Jan. 09, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today that CARE Pharmacies has committed to introducing ActiPatch, Musculoskeletal Pain Therapy medical device to its patients. “With the current opioid crisis here in the United States, as pharmacists, we […]
FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to announce that the UK’s government funded public health service, National Health System (NHS), has approved our application to cover and pay for ActiPatch® Musculoskeletal Pain Therapy. The NHS estimates that almost half […]
FREDERICK, MD, Dec. 12, 2017 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced wearable consumer pain management medical device, ActiPatch, announced today the launch of ActiPatch for Over-The-Counter, drug-free pain relief as an alternative to Opioids. ActiPatch is approved by the FDA for Over-The-Counter sales for the adjunctive treatment of pain […]
BioElectronics Receives FDA Pre-Submission Approval for its Relief of Musculoskeletal Pain Market Clearance Application
FREDERICK, MD , May 11, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (BIEL) , www.bielcorp.com is pleased to report on the outcome of its Pre-Submission meeting on May 9th, 2018 with the US Food and Drug Administration (US FDA). The FDA’s Pre-Submission Program is designed to organize and give guidance and feedback on clinical data and what regulatory pathway should be followed to get market clearance. The focus of the May 9 pre-submission meeting was in discussing the FDA’s feedback on the clinical outcomes and statistical techniques used in reporting the back-pain study.
Upon reviewing pre-submission information on the ActiPatch® back-pain study (https://clinicaltrials.gov/ct2/show/NCT03240146), the FDA provided positive feedback on the clinical results, and guidance on a 510(k) submission to obtain expanded market clearance for over-the-counter (OTC) treatment of musculoskeletal pain. This would make ActiPatch available as a drug-free, safe, pain relief option for the 126 million Americans (one in two adults) who are suffering with some form of musculoskeletal pain. While ActiPatch is already FDA cleared for treatment of pain from knee osteoarthritis (25 million) and plantar fasciitis (1 million annually), expanded market clearance would allow additional products for the back (42 million), neck (19 million), hip (9 million), shoulder (11 million), carpal tunnel (12 million) and many other musculoskeletal complaints.
The company was represented by their clinical R&D team comprising: Sree Koneru, Ph.D., VP Product Development, Ian Rawe, Director Clinical Research of BioElectronics (BIEL), Kenneth McLeod, Ph.D. Director of Clinical Science and Engineering Research, State University of New York at Binghamton and Richard Staelin, Ph.D. Professor Duke University. Dr. Koneru, who led the discussion, expressed confidence in the FDA’s constructive feedback. “We are pleased that the FDA viewed our data and statistical methods favorably. They have provided guidance on how to combine the back-pain study results, along with our previously cleared 510(k), into a single 510(k) submission for obtaining expedited expanded market clearance.”, he said.
An additional pre-submission meeting is scheduled with the FDA on May 29th, 2018 to seek expanded indications in a separate application for OTC treatment of pain and edema following surgical procedures for its RecoveryRx® medical device.
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit www.bielcorp.com
BioElectronics VP of Sales Discusses Pre & Post-operative Pain Relief Surgical Program in "Stock Day" Interview
PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire was thrilled to have Keith Nalepka, VP of Marketing & Sales at BioElectronics (OTC Pink:BIEL) ("the Company"), return to the "Stock Day" podcast. The company has been working hard lately to expand the United Kingdom market with B. Braun in the surgical market and the product opportunity from the recent National Health Service payment approval for its ActiPatch® medical device.
BioElectronics is with B. Braun Medical, Ltd.UK to initiate the "Total Pathways Program" program into B. Braun's 26 geographic markets. The program is for pre-habilitation (treatment that happens prior to surgery) and post-operative recovery. This new program will benefit the majority of the 160,000 UK annual knee, hip, or joint replacements patients. According to Keith, BioElectronics is not just trying establishing a brand, but "to establish the process to a standardize care for pre and post-operative pain."
The company is immensely proud of their team for getting their concept through to the National Health Service (NHS) in the UK. In addition to successes here, the company is hoping to utilize their overseas success by applying data to their US-based efforts.
There are some great potential partnerships currently being discussed at BioElectronics, with the closing of a significant deal just on the horizon.
BioElectronics Corp is approaching their upcoming FDA meetings with confidence. "We have the data to make a very strong case for both broader musculoskeletal and post-operative pain relief indications," said Nalepka. "It's an exciting time for the company, and a really cool little product."
For more details on the Total Pathways Program, news about a partnerships, and information about the company's upcoming meetings with the FDA, follow the link below to the full interview.
https://upticknewswire.com/featured-interview-vp-of-sales-keith-nalepka-of-bioelectronics-corp-otcpink-biel-3/ ;
About BioElectronics
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.
Contact: Paul Knopick, 940.262.3584, pknopick@eandecommunications.com
Safe Harbor Statement
Certain statements contained herein are "forward-looking statements," (as defined in the Private Securities Litigation Reform Act of 1995). BioElectronics Corp. cautions that statements and assumptions made in this news release constitute forward-looking statements; the company makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, and other estimates made by management. Actual results could differ from current projections or implied results. BioElectronics Corp. undertakes no obligation to revise these statements following the date of this news release.
About Uptick Newswire
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network "Stock Day" Podcast. The Uptick Network "Stock Day" Podcast is an extension of Uptick Newswire and has recently launched the Video Interview Studio located in Phoenix, Arizona.
Contact Information
Uptick Newswire LLC
Everett Jolly, CEO/Founder
602-441-3474
10000 N. 31st Avenue C307 Phoenix, AZ 85051
info@upticknewswire.com
www.upticknewswire.com
Release #:812-170554-rl-1141231: |
BioElectronics Up-Date |
Dear Fellow Shareholders, This letter is to report on our recent progress in marketing and product development. We have established the following:
We are continuing to solicit new international and domestic sales and marketing partners for distribution and licensing, while strengthening our relationship with existing partners. To aid in this effort we have engaged an accomplished sales and marketing pharmaceutical consultant to assist in introduction and negotiations of sales and marketing partnerships. US Market Clearance ActiPatch®, Musculoskeletal Pain Therapy We are in the process of expanding the US market clearance from relief of osteoarthritis of the knee pain and plantar fasciitis. Our goal is to obtain general clearance for musculoskeletal pain. To achieve this, we have submitted a chronic back pain clinical study to the US FDA as a formal Pre-Sub. The initial meeting with the FDA is tentatively scheduled for May 9th. Prior guidance from the FDA indicated that a third clinical study was required before expanding the current market indications to cover all musculoskeletal pain. We are hopeful that the process will be completed rapidly, however we will not have a good estimate of this market clearance date until the completion of the May 9th meeting. Postoperative Recovery and Pain We have submitted a formal Pre-Sub to the US FDA for guidance in obtaining market clearance for the palliative treatment of postoperative pain and edema. The application is supported by postoperative clinical studies on breast augmentation and caesarean section. Marketing Expansion We believe that expanded market clearance from the FDA will enhance the market value and attractiveness of the ActiPatch product line. Our economic and clinical studies for the National Health Services allowed us to gain a drug tariff listing for reimbursement in England and Wales allowing the following:
The ActiPatch registry studies report that people buy the device because it is effective, drug-free, has no harmful side effects and overall improves quality of life. We are continually working to solve existing minor issues with the use of ActiPatch. To improve the product, we are introducing custom-design kinesiology tape strips to attach the device to the body. Aside from improving user comfort, this allows us to promote a single multi-purpose box with the added benefit of reducing retail shelf space. We believe this will then allow us to sell the 7-day trial devices from pharmacy shelves. B. Braun UK This is an important development for BioElectronics. B Braun has been using RecoveryRx to improve recovery following joint replacement for many years, although in limited surgeries. However, new advances in day surgery for joint replacement have expanded our opportunity. B. Braun has recently completed a pilot program in the UK evaluating day for joint replacement. The United Kingdom's Group day surgery program for knee and hip replacement patients and is now being implemented on a national basis. Currently there are 80,000 procedures per year involving B Braun. The "fast-track" same day hip and knee replacements are being supported by hospital physiotherapy teams visiting the patient at home and communicating using a special wireless technology tablet. Upon hospital discharge, each patient will be given an ActiPatch medical device and a prescription for 6 additional devices to help accelerate recovery and mitigate the postoperative pain. A similar program is in development for spinal surgeries. On an international level, B. Braun's 54,000 employees are in 60 countries and are separated into additional divisions for hospital care, surgical products, outpatient care, and home care services. It is anticipated that B. Braun's German Group will roll out the same day hip and knee replacement program in the next few months.
Smart Insole – Heel Pain Relief We have redesigned the Smart™ Insole plantar fasciitis insole to enhance user comfort. We are awaiting a written License and Supply Agreement for the product. Clinical Research to Expand Market Clearance and Acceptance Allay®, Menstrual Pain Therapy 28% of women are in the menstrual phase of life and 60% have moderate to severe menstrual pain, or 17% of women. Previously our medical devices were classified as high risk class III by the US FDA. While our existing pilot clinical study for menstrual pain reported exceptional results for menstrual pain, to publish a clinical study and obtain US market clearance, we are collaborating with the University Hospital at Birmingham, UK. The researchers here are world renowned thought leaders in women's health and are conducting a double-blind randomized controlled trial to evaluate the efficacy of ActiPatch in reducing menstrual pain (clinicaltrials.gov listing NCT03394547). You can view the existing clinical evidence and our commercials at https://www.myallay.com/ Prevention of Episodic Migraines Headaches Migraines affect 36 million men, women and children in the United States alone. The facts are:
Chronic pain is now widely understood to be due to central sensitization, which leads to exaggerated pain perception. Migraine is no exception; since it is well known that sensitization of the trigeminovascular pain pathway can occur during a migraine attack. There is pilot data that ActiPatch can help mitigate this sensitization, so a study has been completed to determine the efficacy of ActiPatch in preventing chronic, episodic migraines. The data from the study will be analysed in the next few weeks. We believe this data will allow us to work towards developing a product as a migraine therapy and allowing us to obtain market clearance. Postoperative Recovery and Pain Working with our distributor in Lebanon we are conducting a double blind placebo randomized controlled trial on total knee replacement (clinicaltrial.gov NCT03395444). Through our long standing association with B. Braun UK, RecoveryRx has been determined to be a valuable aid in joint replacement surgery. This clinical study will allow us to gain worldwide recognition and allow for expanded marketing and acceptance of the RecoveryRx as a standard of post-operative care following joint replacement. Interstitial Cystitis (Overactive Bladder and Pelvic Pain) This study is a University of Texas, McGovern Medical School sponsored double blind randomized controlled trial. The goal is to determine how well the ActiPatch therapy works in treating patients with interstitial cystitis, bladder pain syndrome and overactive bladder. Interstitial cystitis and bladder pain syndrome are chronic bladder health conditions that greatly affect quality of life. These conditions create intermittent feelings of pain and pressure in the bladder area. The study is expected to recruit 60 women who are urology patients of the University's hospital. At least 35 million Americans have overactive bladder. Lower urinary tract symptoms, urgency, and pelvic pain are common complaints to urologists and primary care physicians. Additional Bioelectronic Product Opportunities As we develop the organizational structure we envision additional opportunities in chronic wounds, neuropathy, hypertensive therapy, etc. Most importantly future growth is not dependent on large capital outlays for research and development. Immediate Sales Growth We anticipate imminent solid sales growth from the following programs:
Thank you for your support. Sincerely,
______________________ |
FREDERICK, MD., May 31, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), maker of advanced medical devices announces that B. Braun Ltd, of Sheffield, UK has recently completed development of its same day surgical TOTAL Pathway program for joint replacements which includes BioElectronics medical devices. The program is being launched by B. Braun’s UK Group to improve care and reduce the UK healthcare cost of its 160,000 annual hip and knee replacement procedures.
The “fast-track” same day hip and knee replacements are being supported by hospital physiotherapy teams visiting the patient at home and communicating using a specialized wireless tablet. Each patient will be given an ActiPatch medical device and a prescription for 6 additional ActiPatch devices. A similar program is being implemented for spinal surgeries.
Phil Cleary, Senior Product Group Manager, stated that “our TOTAL Pathway program enhances our commitment to patient safety, post-operative care, as well as significantly reducing healthcare costs and hospital stays.” Treating post-surgical pain requires a multifaceted approach. In trials, ActiPatch was well received and produced positive outcomes. We look forward to making this program a success, in the UK and other countries where B. Braun operates.
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.
About B. Braun Medical Ltd
B. Braun Medical Ltd, UK, https://www.bbraun.co.uk/ is a member of the B. Braun Group, https://www.bbraun.com/en.html one of the world´s leading healthcare companies. On an international level, B. Braun’s 54,000 employees are in 60 countries and are separated into additional divisions for hospital care, surgical products, outpatient care, and home care services.
Keep in mind partners are happening and licensed ones at that.
The back study will not go in as a new submission, it is included in the knee and ankle submission so this will happen quicker than most would believe. Well actually the back study will be added to the prior submission, I don't want to confuse you
Watch how huge the Co-Branding gets. How many names besides Pain Gear?
Increasing shareholder value=7 components of shareholder value.
• Revenue
• Operating Margin
• Cash Tax Rate
• Incremental Capital Expenditure
• Investment in Working Capital
• Cost of Capital
• Competitive Advantage Period
Within the next 120 days BIEL will have in place-
Full body clearance minus the Migraine, anticipated clearance at a later date based upon the fact that this is a preventative study and the patients must have signs of a migraine coming, this study is a little more complicated.
Licensed partners (Major)
Equity partners
At least 2 huge retail chains
Let’s add on a few more distributors. Why not? Lol
NHS-first week of April, keep in mind not the only week, this is lifetime!
There will be other EU States that will duplicate the NHS and this will be coupled with licenses being sold to partners. What price, how much in royalties will soon be determined.
The August financials will and should be the strength of evidence that a certain person has established a supply chain that will be second to none.
I should mention that sales makeup only one component of the revenue stream, this is where my opinion may differ from the good posters on the BIEL board.
Revenue is the total amount taken in by a business in a set period of time.
This can include royalties, license fees and equity from partners and sales.
BIEL cannot have millions in sales without including the other revenue streams mentioned above.
My revenue forecast including sales may be different than others.
Great rewards will follow in due time. Waiting on the FDA protocol. Which means pre-submission. Guidance, rules and timing will be part of the protocol.(Looks like May-June clearance.)
Migraine clinical results will still be the huge one for the FDA protocol.(August-September clearance on positive results.)
NHS is the first of many EU States getting on board. Pretty good health systems across the pond. Sweden next!
The back pain study will obtain US FDA clearance for relief of musculoskeletal pain. Migraine headaches are not musculoskeletal. Migraines and musculoskeletal pain are both neurological disorders. Two FDA clearances!!!!!!!!!!!!!
SEC-much ado about nothing!
Partners-much ado about something!
12/7/2017 - Try and Tell US Launch, gets a 7 Day ActiPatch to US residents for shipping and handling costs of $4.95
12/7/17 - BIEL closes a deal with ANDA for National Distribution, ANDA has 60,000 commercial customers and is owned by TEVA Pharma, TEVA has extensive business dealings with the NHS
1/4/2018 - ActiPatch gains admission to the UK NHS Drug Tariff as a covered medical device, The NHS is the largest single healthcare delivery organization in the world
1/9/2018 - CARE Pharmacies will be handling the ActiPatch, CARE is an organization of 90 pharmacies in 17 states, CARE will be educating patients on the benefits of drug-free pain relief through Pain Consultations
1/16/2018 - Allay Menstrual Clinical Study is fully enrolled, taking place at the prestigious Birmingham Women's Hospital,an NHS Foundation Hospital
1/22/2018 - BIEL signs deal with Performance Health, 120 outside sales reps, 40 inside reps, KN interview
1/22/2018 - BIEL signs deal with MundiPharma in Australia and 8 other countries, Mundi is associated with Purdue Pharma, KN interview
1/22/2018 - Back Pain Study is complete, BIEL has dialogue ongoing with FDA for submission of Study to expand ActiPatch indications, KN interview
1/22/2018 - Migraine Study will get the full attention of staff now that the Back Study has been completed
1/22/2018 - BIEL in talks with Walmart
1/22/2018 - Meeting scheduled with CVS
This is the last 2 months of activity for BIEL. Any other OTC company would be dancing in the Street if they had accomplished this much in the last year.
The NHS Approval has opened new doors for BIEL and will continue to do so for many years.
FREDERICK, Md., Jan. 04, 2018 (GLOBE NEWSWIRE) -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com makes wearable, drug-free chronic pain therapy medical devices. It is pleased to announce that the UK’s government-funded public health service, National Health System (NHS), has approved our application to cover and pay for ActiPatch® Musculoskeletal Pain Therapy. The NHS estimates that almost half of the 50 million UK adults may be living with chronic-pain¹, which is why there are more than 100,000 physician visits every day for musculoskeletal pain alone².
The ActiPatch is a drug-free, wearable medical device that regulates peripheral nerve activity to provide pain relief. The NHS based its decision considering strong clinical evidence and a health economics study, which found that ActiPatch significantly decreased pain and improved quality of life, while reducing overall healthcare costs by 42% (58.5% reduction in physician appointment costs, 35% reduction in prescription medication costs).
“This is a major win for pain sufferers in the UK, since they will now be able to obtain a prescription for ActiPatch, the cost of which will be covered by the government,” stated Ian Rawe, Ph.D., Director of Clinical Research at BioElectronics. “We commend this move by the NHS, as this will open up the doors for reimbursement in the US and other managed care markets. This will likely have a tremendous impact on our sales and marketability of the product in the UK and elsewhere,” said Keith Nalepka, VP of Sales & Marketing at BioElectronics.
With the addition of ActiPatch to list of approved treatments, chronic pain sufferers now have access to paid safe, drug-free chronic pain relief. The ActiPatch will be listed for payment coverage in April.
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.
References
1 NHS, "NHS Choices," January 2018. [Online].http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf
Available: https://www.nhs.uk/news/medical-practice/almost-half-of-all-uk-adults-may-be-living-with-chronic-pai....
2 Arthritis Research UK, "Muscloskeletal Matters," Keele University, 2009
ActiPatch Cost Assessment Study Used By UK's NHS
http://www.actipatch.com/actipatch/wp-content/uploads/2014/11/ActiPatch-3-month-Cost-Study-Final.pdf
This improvement translated into reduced utilization of healthcare services, leading to a 36.8% reduction in health care costs to the NHS over a 3-month period, even after accounting for the cost of the ActiPatch device
Conclusion
Utilizing ActiPatch® as a chronic pain therapy treatment improves patient quality of life, while reducing the economic burden to the NHS.
"Almost half the adult population is living with chronic pain," the Daily Mail reports. A major new review suggests that around 28 million adults in the UK are affected by some type of chronic pain (pain that lasts for more than three months). Read More Link
https://www.nhs.uk/news/medical-practice/almost-half-of-all-uk-adults-may-be-living-with-chronic-pain/
February 06, 2017 09:05 ET
FREDERICK, MD--(Marketwired - Feb 6, 2017) - BioElectronics Corporation (OTC PINK: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the knee.
BioElectronics is an electroceutical company that develops wearable, neuromodulation devices to safely mitigate neurological diseases and improve quality of life. Our innovative pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulate electrical activity of the nervous system. The neuromodulation basis of PSWT presents significant opportunities for BioElectronics to develop optimized technology for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications.
Our current OTC product line includes ActiPatch® Musculoskeletal Pain Therapy, Allay® Menstrual Pain Therapy, Smart Insole™ Heel Pain Therapy, and RecoveryRx® Post-operative and Chronic Wounds Therapy. The US FDA clearance is for our flagship product the ActiPatch® Musculoskeletal Pain Therapy, developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides 720-hours (90, 8-hour treatments) of on/off therapy for $30.00 retail. Most users obtain relief with only 8 hours per day of use, so the device will generally last several months, depending on use. ActiPatch Provides:
About BioElectronics Corporation
BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: For more information, please visit www.bielcorp.com.
How to Order an ActiPatch®?
Visit tryactipatch.com to place your order for the ActiPatch® today.
www.tryactipatch.com
BioElectronics Corporation
301-874-4980
info@bielcorp.com
4539 Metropolitan Court
Frederick, MD 21704
ActiPatch Healthcare Utilization Study Link
http://www.harmonyhealth.se/wp-content/uploads/2017/10/ActiPatchHealthcareCostStudy.pdf
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |